Sophia Genetics Sophia Genetics Raises $234M in IPO, Eyes Additional Partnerships The stock opened at $18 per share, valuing the Switzerland- and Boston-based bioinformatics company at $1.14 billion. M&A in Genomics/MDx Sector Surges in H1 2021 Premium Innovations in the liquid biopsy and oncology space gained investors' attention, leading to a spike in acquisition deals in the first half of the year. Sophia Genetics Increases IPO Target to $221M The company will now offer 13 million common shares at $17 to $19 per share, raising its proceeds target from the previously announced $100 million. Sophia Genetics Files for $100M IPO, Inks Cancer Data Deal With GE Healthcare Sophia, which will trade on the Nasdaq, seeks to raise $100 million in an IPO, and separately announced a partnership with GE Healthcare. Sophia Genetics, Hitachi Partner on Data-Driven Precision Medicine The companies initially plan to expand the commercialization of Sophia's DDM analytics platform and Hitachi's digital healthcare technology in certain geographic areas. Feb 12, 2021 People in the News: New Appointments at Sema4, Sophia Genetics, Qiagen, More Feb 8, 2021 Sophia Genetics, Spanish Lung Cancer Group Team up to Predict Lung Cancer Treatment Response Jan 22, 2021 People in the News: New Appointments at Foundation Medicine, Sophia Genetics, Circulogene; More Nov 20, 2020 People in the News: New Appointments at Natera, Quanterix, Sophia Genetics, More Oct 20, 2020 Sophia Genetics Using $110M Funding Round to Focus on New Markets, Continued Collaboration Premium Oct 1, 2020 Sophia Genetics Closes $110M Series F Funding Round Feb 27, 2020 Sophia Genetics to Provide Access to Genomic Analysis Platform to MGI Customers Feb 26, 2020 Twist Bioscience, Sophia Genetics Team on Genomic Analysis Feb 14, 2020 People in the News: Scott Mendel, Hany Massarany, Edwin Hendrick, Philippe Menu, More Nov 22, 2019 People in the News: Mary-Claire King, Patrick Finn, Milton Silva-Craig, More Oct 25, 2019 New Products Posted to GenomeWeb: Biocartis, Synthego, Sophia Genetics Oct 15, 2019 Sophia Genetics, Genomenon to Integrate Genomic Analysis, Search Engine Platforms Aug 6, 2019 Sophia Genetics Teams With ADC Therapeutics on Biomarker Discovery for Lymphoma Treatment Apr 11, 2019 Sophia Genetics Gets CE-IVD Mark for Cancer Detection Solution Jan 4, 2019 Sophia Genetics Closes $77M Funding Round Oct 31, 2018 Sophia Genetics Integrating Paragon's CleanPlex Into AI Platform Jun 16, 2018 Sophia Genetics Acquires Interactive Biosoftware Premium Feb 20, 2018 Sophia Genetics Looks to Marry Imaging, Genomic Analysis for MDx Premium Feb 6, 2018 Sophia Genetics Gains CE-IVD Mark for Leukemia Assay Sep 13, 2017 Sophia Genetics Raises $30M In New Funding Load More Breaking News Singular Genomics Systems Reports No Revenues, Increased Net Loss for Q2 Burning Rock Biotech, Impact Therapeutics Partner on CDx for PARP Inhibitor Senaparib Gene Editing Analysis Firm SeQure Dx Closes $17.5M Series A Funding Round Resolve Biosciences, Zeiss Partner to Enhance Spatial Biology Imaging Tech EliTechGroup Obtains CE Mark for Saliva Use With SARS-CoV-2 Test Waters Q2 Revenues Up 31 Percent The Scan And Back The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database. Lacks Family Hires Attorney A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports. For the Unknown The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona. PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.